Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...

UPDATED: Friday, Jan. 3 at 2:45 p.m. ET GSK’s IL-5 inhibitor Nucala scored a nod in China to treat people with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP), a ...

In September 2020, the Company launched tetravalent influenza flu vaccine, Fluarix Tetra to help combat influenza.In June, 2021 Company launched the Nucala, first anti-IL5 drug, auto-injector ...

Steep new fines — more than many people make in a month — have made the streets of Ho Chi Minh City and Hanoi less freewheeling than they used to be. By Damien Cave When Colombia’s ...

Vice President Jagdeep Dhankhar expressed hope that the entire country would soon adopt the Uniform Civil Code (UCC), following Uttarakhand's implementation of it. He criticized those opposing the ...

Disgusted by Democrats’ ongoing support for the genocide in Gaza, some Muslim and Arab American voters are embracing third-party candidates and community-based forms of political engagement ...

The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience.

Stocks Sink as Investors Worry About China’s A.I. Advances A jolt of panic hit technology stocks on Monday, with investors rattled by fears that A.I. advances by Chinese upstarts could threaten ...

However, if the minister resigns his position in government, he returns to the Knesset, and pushes out the last MK on the list. Information ...